Ceribelli, Angela
 Distribuzione geografica
Continente #
NA - Nord America 4.039
AS - Asia 2.971
EU - Europa 1.190
AF - Africa 701
SA - Sud America 597
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.508
Nazione #
US - Stati Uniti d'America 3.956
SG - Singapore 1.794
SC - Seychelles 610
CN - Cina 527
BR - Brasile 499
VN - Vietnam 285
IT - Italia 270
FI - Finlandia 203
IE - Irlanda 144
DE - Germania 122
FR - Francia 88
IN - India 88
GB - Regno Unito 82
HK - Hong Kong 80
NL - Olanda 62
AR - Argentina 41
CA - Canada 35
SE - Svezia 30
MX - Messico 29
NG - Nigeria 29
RU - Federazione Russa 28
IQ - Iraq 23
PL - Polonia 23
ZA - Sudafrica 23
BD - Bangladesh 22
MK - Macedonia 20
TR - Turchia 20
ES - Italia 19
EC - Ecuador 17
JP - Giappone 17
PK - Pakistan 17
CZ - Repubblica Ceca 15
ID - Indonesia 12
PH - Filippine 12
MA - Marocco 11
BE - Belgio 10
CH - Svizzera 10
CO - Colombia 10
SA - Arabia Saudita 10
UA - Ucraina 10
CL - Cile 9
AE - Emirati Arabi Uniti 8
GR - Grecia 8
IL - Israele 8
TN - Tunisia 8
UZ - Uzbekistan 8
AT - Austria 7
JO - Giordania 7
PE - Perù 7
AU - Australia 6
VE - Venezuela 6
EG - Egitto 5
JM - Giamaica 5
KR - Corea 5
LB - Libano 5
BG - Bulgaria 4
DK - Danimarca 4
KZ - Kazakistan 4
NO - Norvegia 4
PY - Paraguay 4
RO - Romania 4
AL - Albania 3
DZ - Algeria 3
HN - Honduras 3
KE - Kenya 3
LT - Lituania 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
EE - Estonia 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
ML - Mali 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
SI - Slovenia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
Totale 9.497
Città #
Singapore 797
Chandler 606
Ashburn 513
Dallas 355
San Jose 346
The Dalles 294
Shanghai 228
Helsinki 203
Boardman 168
Beijing 155
New York 151
Dublin 142
Wilmington 133
Ho Chi Minh City 114
Hong Kong 71
Los Angeles 71
Hanoi 65
Milan 59
Paris 59
San Mateo 54
Amsterdam 45
São Paulo 38
Ann Arbor 34
London 33
Council Bluffs 31
Falkenstein 31
Santa Clara 28
Benin City 27
Pune 27
Lawrence 26
Princeton 26
Leawood 23
Naples 23
Phoenix 22
Belo Horizonte 20
Columbus 20
Warsaw 18
Brooklyn 17
Chennai 17
Stockholm 16
Woodbridge 16
Frankfurt am Main 15
Rio de Janeiro 15
Seattle 15
Da Nang 13
Fairfield 13
Montreal 13
Rome 13
Assago 12
Tokyo 12
Brno 11
Johannesburg 11
Mexico City 11
Orem 11
San Francisco 11
Boston 10
Brasília 10
Brussels 10
Haiphong 10
Baghdad 9
Munich 9
Skopje 9
Chicago 8
Curitiba 8
Dhaka 8
Sassari 8
Hyderabad 7
Tashkent 7
Toronto 7
Amman 6
Aurora 6
Buffalo 6
Fortaleza 6
Hillsboro 6
Hải Dương 6
Istanbul 6
Lima 6
Osasco 6
Porto Alegre 6
Quito 6
San Diego 6
Thái Bình 6
Trieste 6
Turin 6
Zurich 6
Bitola 5
Caxias do Sul 5
Guarulhos 5
Hangzhou 5
Houston 5
Jakarta 5
Jundiaí 5
Kingston 5
Kocaeli 5
Lahore 5
Miami 5
Moscow 5
Poplar 5
Praia Grande 5
Santiago 5
Totale 5.589
Nome #
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 686
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 203
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy 137
UTILIZZO DELLA MEPACRINA COME TERAPIA DELLE MANIFESTAZIONI CUTANEE NELLE CONNETTIVITI 136
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 128
Personalized medicine in rheumatology : the paradigm of serum autoantibodies 126
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population 120
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 106
Additional organs involved in antiphospholipid syndrome : eye, ear-nose-throat, lung, gastroenteric system, endocrine glands 106
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 105
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review 102
Safety issues and concerns of new immunomodulators in rheumatology 102
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies 101
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 101
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction 98
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy 96
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 95
Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression 94
Lessons learned from twins in autoimmune and chronic inflammatory diseases 91
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 90
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease 90
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 89
Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis 86
Effects of type II collagen epitope carbamylation and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis 83
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma 83
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 83
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS) 79
PFAPA syndrome and Behçet’s disease : a comparison of two medical entities based on the clinical interviews performed by three different specialists 79
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 76
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 76
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis : a Critical Review 75
Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis 75
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis 74
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 74
Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement 74
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al 73
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 73
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals 71
AUTOANTIBODY TO RNA-PROTEIN COMPLEX DETECTED BY QUANTITATIVE PCR 71
Disease knowledge index and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 71
A new immunoprecipitation-real time quantitative PCR assay for anti-Th/To and anti-U3RNP antibody detection in systemic sclerosis 70
MicroRNAs in rheumatoid arthritis 70
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 69
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 69
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 68
Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis 68
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement 66
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 65
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies 65
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 63
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 63
Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis 63
Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways 62
The Th17 axis in psoriatic disease : pathogenetic and therapeutic implications 62
Seronegative reactive spondyloarthritis and the skin 62
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature 61
Epigenetic Methods and Twin Studies 60
MicroRNAs and autoimmunity 60
Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others 60
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies 60
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 59
Elastic properties of the ascending aorta in patients with rheumatoid arthritis 59
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits 57
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 57
Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 56
MicroRNA-146a in autoimmunity and innate immune responses 56
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine 56
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD) 56
The interplay of epigenetics and epidemiology in autoimmune diseases: time for geoepigenetics 55
Cancer in connective tissue disease 55
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 54
Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study 54
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 54
Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay 54
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies 54
Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients 53
Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis 53
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy 53
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 53
The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to know 52
Medical cannabis and cannabinoids in rheumatology: where are we now? 52
The geoepidemiology of autoimmune liver disease 51
Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining 51
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals 51
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus 50
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis 50
International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 50
Neuropsychiatric aid in children born to patients with rheumatic diseases 50
Unusual association between pure red cell aplasia and primary Sjögren's syndrome: a case report 50
Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study 49
Lupus T cells switched on by DNA hypomethylation via microRNA? 49
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases 49
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 48
Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies 48
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 48
ANTICORPI ANTI-CCP: LIMITI E SVANTAGGI 48
Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma 47
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 47
Cardiological features in idiopathic inflammatory myopathies 47
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 47
Totale 7.746
Categoria #
all - tutte 51.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.791


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 26 2 41
2021/2022147 8 2 2 33 2 1 4 18 12 16 29 20
2022/20231.483 77 103 122 191 129 142 5 180 254 132 128 20
2023/20241.167 127 77 257 92 48 181 77 32 20 60 64 132
2024/20252.428 38 37 636 57 83 227 144 131 293 400 207 175
2025/20264.091 792 265 412 341 191 247 1.230 227 204 182 0 0
Totale 9.588